2m 2m 2m 2m 2m 2m 2m
IMMUNIC (IMUX)
NASDAQ
$7.92-$0.72 (-8.33%)
Price as of Oct 02, 2026 6:32 PM EDT- $117.9MMarket Cap
- -10.31%1-Year Change
- BiotechnologyIndustry
IMMUNIC (IMUX)
$7.92-$0.72 (-8.33%)
IMUX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.64 | ||
Change | -$0.66 (-7.10%) | ||
Open | $9.30 | ||
High | $9.47 | ||
Low | $8.60 | ||
Previous Close | $9.30 | ||
Volume | 559,786 | ||
30-Day Average Volume | 422,288 | ||
1-Week Change | -7.30% | ||
1-Month Change | -40.74% | ||
1-Year Change | -10.31% | ||
3-Year Change | -41.22% | ||
5-Year Change | -88.98% | ||
Fundamentals | |||
Shares Outstanding | 13.6M | ||
Total Assets | $159.2M | ||
Market Cap | $117.9M | ||
Enterprise Value | -$37.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$34.1M | ||
Free Cash Flow | -$31.2M | ||
EBIT | -$34.1M | ||
EBITDA | -$34.1M | ||
Net Working Capital | $126.6M | ||
EPS | -$0.80 | ||
Enterprise Value/EBITDA | 1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -11 | ||
PEG | -0 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 04/27/2026 | ||
Earnings & Revenue